Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

The mitosis-specific antibody anti-phosphohistone-H3 (PHH3) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria.

Ribalta T, McCutcheon IE, Aldape KD, Bruner JM, Fuller GN.

Am J Surg Pathol. 2004 Nov;28(11):1532-6.

PMID:
15489659
2.

Sensitivity and usefulness of anti-phosphohistone-H3 antibody immunostaining for counting mitotic figures in meningioma cases.

Fukushima S, Terasaki M, Sakata K, Miyagi N, Kato S, Sugita Y, Shigemori M.

Brain Tumor Pathol. 2009;26(2):51-7. doi: 10.1007/s10014-009-0249-9. Epub 2009 Oct 27.

PMID:
19856215
3.

Prognostic significance of the mitotic index using the mitosis marker anti-phosphohistone H3 in meningiomas.

Kim YJ, Ketter R, Steudel WI, Feiden W.

Am J Clin Pathol. 2007 Jul;128(1):118-25.

PMID:
17580279
4.

Better see to better agree: phosphohistone H3 increases interobserver agreement in mitotic count for meningioma grading and imposes new specific thresholds.

Duregon E, Cassenti A, Pittaro A, Ventura L, Senetta R, Rudà R, Cassoni P.

Neuro Oncol. 2015 May;17(5):663-9. doi: 10.1093/neuonc/nov002. Epub 2015 Feb 1.

5.

Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas.

Colman H, Giannini C, Huang L, Gonzalez J, Hess K, Bruner J, Fuller G, Langford L, Pelloski C, Aaron J, Burger P, Aldape K.

Am J Surg Pathol. 2006 May;30(5):657-64.

PMID:
16699322
6.

Useof anti-phosphohistone H3 immunohistochemistry to determine mitotic rate in thin melanoma.

Casper DJ, Ross KI, Messina JL, Sondak VK, Bodden CN, McCardle TW, Glass LF.

Am J Dermatopathol. 2010 Oct;32(7):650-4. doi: 10.1097/DAD.0b013e3181cf7cc1.

PMID:
20559123
7.

Does mitosis-specific marker phosphohistone H3 help the grading of upper tract urothelial carcinomas in cell blocks?

Solomides CC, Birbe RC, Nicolaou N, Bagley D, Bibbo M.

Acta Cytol. 2012;56(3):285-8. doi: 10.1159/000337649. Epub 2012 Apr 26.

PMID:
22555531
8.

Mitotic count by phosphohistone H3 immunohistochemical staining predicts survival and improves interobserver reproducibility in well-differentiated neuroendocrine tumors of the pancreas.

Voss SM, Riley MP, Lokhandwala PM, Wang M, Yang Z.

Am J Surg Pathol. 2015 Jan;39(1):13-24. doi: 10.1097/PAS.0000000000000341.

PMID:
25353284
9.

pHH3 immunostaining improves interobserver agreement of mitotic index in thin melanomas.

Schimming TT, Grabellus F, Roner M, Pechlivanis S, Sucker A, Bielefeld N, Moll I, Schadendorf D, Hillen U.

Am J Dermatopathol. 2012 May;34(3):266-9. doi: 10.1097/DAD.0b013e31823135a3.

PMID:
22197861
10.

Phosphohistone-H3 Proliferation Index Is Superior to Mitotic Index and MIB-1 Expression as a Predictor of Recurrence in Human Meningiomas.

Winther TL, Arnli MB, Salvesen Ø, Torp SH.

Am J Clin Pathol. 2016 Oct;146(4):510-20. doi: 10.1093/ajcp/aqw141.

PMID:
27686177
11.

Two mitosis-specific antibodies, MPM-2 and phospho-histone H3 (Ser28), allow rapid and precise determination of mitotic activity.

Tapia C, Kutzner H, Mentzel T, Savic S, Baumhoer D, Glatz K.

Am J Surg Pathol. 2006 Jan;30(1):83-9.

PMID:
16330946
12.

Phosphohistone H3 expression correlates with manual mitotic counts and aids in identification of "hot spots" in fibroepithelial tumors of the breast.

Ginter PS, Shin SJ, Liu Y, Chen Z, D'Alfonso TM.

Hum Pathol. 2016 Mar;49:90-8. doi: 10.1016/j.humpath.2015.10.012. Epub 2015 Nov 5.

PMID:
26826415
13.

The accuracy of meningioma grading: a 10-year retrospective audit.

Willis J, Smith C, Ironside JW, Erridge S, Whittle IR, Everington D.

Neuropathol Appl Neurobiol. 2005 Apr;31(2):141-9.

PMID:
15771707
14.

Mitosin and pHH3 predict poorer survival in astrocytomas WHO grades II and III.

Varughese RK, Lind-Landström T, Habberstad AH, Salvesen Ø, Haug CS, Sundstrøm S, Torp SH.

J Clin Pathol. 2016 Jan;69(1):26-34. doi: 10.1136/jclinpath-2015-202983. Epub 2015 Jul 17.

PMID:
26188054
15.

Mitosis-specific marker phospho-histone H3 in the assessment of mitotic index in uterine smooth muscle tumors: a pilot study.

Veras E, Malpica A, Deavers MT, Silva EG.

Int J Gynecol Pathol. 2009 Jul;28(4):316-21. doi: 10.1097/PGP.0b013e318193df97.

PMID:
19483635
16.

Comparative investigation of proliferation markers and their prognostic relevance in human meningiomas.

Torp SH, Lindboe CF, Granli US, Moen TM, Nordtømme T.

Clin Neuropathol. 2001 Sep-Oct;20(5):190-5.

PMID:
11594503
17.

Scoring the percentage of Ki67 positive nuclei is superior to mitotic count and the mitosis marker phosphohistone H3 (PHH3) in terms of differentiating flat lesions of the bladder mucosa.

Gunia S, Kakies C, Erbersdobler A, Koch S, May M.

J Clin Pathol. 2012 Aug;65(8):715-20. doi: 10.1136/jclinpath-2011-200532. Epub 2012 May 3.

PMID:
22554964
18.

Phosphorylated Histone H3 (PHH3) as a Novel Cell Proliferation Marker and Prognosticator for Meningeal Tumors: A Short Review.

Elmaci İ, Altinoz MA, Sari R, Bolukbasi FH.

Appl Immunohistochem Mol Morphol. 2017 Aug 2. doi: 10.1097/PAI.0000000000000499. [Epub ahead of print]

PMID:
28777144
19.

Value of counting positive PHH3 cells in the diagnosis of uterine smooth muscle tumors.

Pang SJ, Li CC, Shen Y, Liu YZ, Shi YQ, Liu YX.

Int J Clin Exp Pathol. 2015 May 1;8(5):4418-26. eCollection 2015.

20.

The potential value of phosphohistone-h3 mitotic index determined by digital image analysis in the assessment of pancreatic endocrine tumors in fine-needle aspiration cytology specimens.

Draganova-Tacheva R, Bibbo M, Birbe R, Daskalakis C, Solomides C.

Acta Cytol. 2013;57(3):291-5. doi: 10.1159/000350885. Epub 2013 Apr 25.

PMID:
23635399

Supplemental Content

Support Center